SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-09-225751
Filing Date
2009-11-05
Accepted
2009-11-05 17:15:52
Documents
7
Period of Report
2009-09-30
Filing Date Changed
2009-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 471004
2 LICENSE AGREEMENT BETWEEN THE COMPANY AND THE DANA-FARBER CANCER INSTITUTE dex101.htm EX-10.1 147633
3 LICENSE AGREEMENT BETWEEN THE COMPANY AND POWER3 MEDICAL PRODUCTS, INC. dex102.htm EX-10.2 96773
4 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex311.htm EX-31.1 9525
5 CERTIFICATIONS PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 dex312.htm EX-31.2 9484
6 CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 3752
7 CERTIFICATIONS PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 3797
  Complete submission text file 0001193125-09-225751.txt   743338
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

IRS No.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30975 | Film No.: 091162037
SIC: 3826 Laboratory Analytical Instruments
Assistant Director 10